CompletedPhase 2

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

NCT03533257

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Clinical Neuroscience Solutions, Inc. - Jacksonville

Jacksonville, Florida, United States

+10 additional locations

Save this trial

Clinical Neuroscience Solutions, Inc. - JacksonvilleJacksonville, Florida, United States
Clinical Neuroscience Solutions, Inc. - OrlandoOrlando, Florida, United States
International Medical Investigational Centers (IMIC)Palmetto Bay, Florida, United States
Rush University Medical CenterChicago, Illinois, United States
University of Kansas Clinical Research CenterFairway, Kansas, United States
Massachusetts General HospitalBoston, Massachusetts, United States
Rowan University School of Osteopathic MedicineStratford, New Jersey, United States
Mount Sinai Alzheimer's Disease Research CenterNew York, New York, United States
Columbia UniversityNew York, New York, United States
Hospital of the University of Pennsylvania, Penn Memory CenterPhiladelphia, Pennsylvania, United States
Genesis NeuroScience ClinicKnoxville, Tennessee, United States